News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
103,584 Results
Type
Article (7397)
Company Profile (43)
Press Release (96136)
Multimedia
Podcasts (21)
Webinars (5)
Section
Business (29223)
Career Advice (150)
Deals (4253)
Drug Delivery (48)
Drug Development (14690)
Employer Resources (12)
FDA (3121)
Job Trends (2181)
News (51872)
Policy (6353)
Tag
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (447)
Accelerated approval (22)
Adcomms (8)
Allergies (55)
Alliances (9268)
ALS (47)
Alzheimer's disease (401)
Antibody-drug conjugate (ADC) (170)
Approvals (3096)
Artificial intelligence (184)
Autoimmune disease (99)
Automation (15)
Bankruptcy (20)
Best Places to Work (1822)
BIOSECURE Act (17)
Biosimilars (167)
Biotechnology (31)
Bladder cancer (54)
Brain cancer (18)
Breast cancer (155)
Cancer (1265)
Cardiovascular disease (71)
Career advice (133)
Career pathing (7)
CAR-T (65)
CDC (11)
Cell therapy (222)
Cervical cancer (11)
Clinical research (13091)
Collaboration (590)
Company closure (3)
Compensation (120)
Complete response letters (48)
COVID-19 (626)
CRISPR (17)
C-suite (235)
Cystic fibrosis (18)
Data (1859)
Denatured (6)
Depression (18)
Dermatology (28)
Diabetes (93)
Diagnostics (649)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (119)
Drug pricing (42)
Drug shortages (2)
Duchenne muscular dystrophy (93)
Earnings (11188)
Editorial (20)
Employer branding (3)
Employer resources (10)
Events (13513)
Executive appointments (227)
FDA (4125)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (367)
Gene editing (56)
Generative AI (27)
Gene therapy (236)
GLP-1 (174)
Government (1441)
Grass and pollen (1)
Guidances (90)
Healthcare (2041)
HIV (15)
Huntington's disease (19)
IgA nephropathy (22)
Immunology and inflammation (108)
Immuno-oncology (39)
Indications (36)
Infectious disease (728)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (49)
Intellectual property (47)
Interviews (13)
IPO (2020)
IRA (16)
Job creations (402)
Job search strategy (123)
JPM (9)
Kidney cancer (5)
Labor market (11)
Layoffs (74)
Leadership (3)
Legal (577)
Liver cancer (14)
Longevity (19)
Lung cancer (182)
Lymphoma (90)
Machine learning (22)
Management (2)
Manufacturing (420)
MASH (32)
Medical device (1210)
Medtech (1230)
Mergers & acquisitions (2456)
Metabolic disorders (226)
mRNA (42)
Multiple sclerosis (49)
NASH (2)
Neurodegenerative disease (109)
Neuropsychiatric disorders (10)
Neuroscience (714)
NextGen: Class of 2026 (717)
Non-profit (374)
Now hiring (25)
Obesity (86)
Opinion (77)
Ovarian cancer (47)
Pain (35)
Pancreatic cancer (45)
Parkinson's disease (72)
Partnered (10)
Patents (104)
Patient recruitment (125)
Peanut (28)
People (9000)
Pharmaceutical (10)
Pharmacy benefit managers (7)
Phase 1 (4287)
Phase 2 (5463)
Phase 3 (4790)
Pipeline (2189)
Policy (132)
Postmarket research (301)
Preclinical (1701)
Press Release (66)
Prostate cancer (51)
Psychedelics (8)
Radiopharmaceuticals (50)
Rare diseases (273)
Real estate (974)
Recruiting (4)
Regulatory (5979)
Reports (13)
Research institute (417)
Resumes & cover letters (16)
Rett syndrome (11)
RNA editing (5)
RSV (23)
Schizophrenia (33)
Series A (71)
Series B (41)
Service/supplier (3)
Sickle cell disease (22)
Special edition (6)
Spinal muscular atrophy (26)
Sponsored (19)
Startups (613)
State (1)
Stomach cancer (5)
Supply chain (24)
Tariffs (21)
The Weekly (15)
Vaccines (340)
Venture capital (19)
Weight loss (40)
Women's health (10)
Date
Today (16)
Last 7 days (163)
Last 30 days (638)
Last 365 days (6720)
2026 (2500)
2025 (6455)
2024 (6874)
2023 (7491)
2022 (9482)
2021 (9906)
2020 (8516)
2019 (6046)
2018 (4657)
2017 (5231)
2016 (4718)
2015 (5424)
2014 (3814)
2013 (2968)
2012 (3068)
2011 (3222)
2010 (2655)
Location
Africa (102)
Alabama (19)
Alaska (1)
Arizona (22)
Arkansas (3)
Asia (8588)
Australia (992)
California (2658)
Canada (541)
China (493)
Colorado (58)
Connecticut (120)
Delaware (123)
Europe (15418)
Florida (374)
Georgia (53)
Hawaii (1)
Idaho (14)
Illinois (116)
India (45)
Indiana (76)
Iowa (10)
Japan (127)
Kansas (10)
Kentucky (16)
Louisiana (2)
Maine (24)
Maryland (499)
Massachusetts (1998)
Michigan (35)
Minnesota (87)
Mississippi (4)
Missouri (32)
Montana (5)
Nebraska (1)
Nevada (17)
New Hampshire (6)
New Jersey (882)
New Mexico (4)
New York (768)
North Carolina (355)
North Dakota (9)
Northern California (1329)
Ohio (74)
Oklahoma (12)
Oregon (6)
Pennsylvania (449)
Puerto Rico (5)
Rhode Island (8)
South America (144)
South Carolina (4)
Southern California (1093)
Tennessee (12)
Texas (400)
United States (9286)
Utah (52)
Virginia (37)
Washington D.C. (10)
Washington State (204)
West Virginia (1)
Wisconsin (16)
103,584 Results for "cmc biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
·
2 min read
Press Releases
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC)
April 15, 2026
·
4 min read
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Press Releases
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
November 20, 2025
·
7 min read
Press Releases
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
April 29, 2026
·
4 min read
IN PARTNERSHIP WITH API
Lean Derisking: Smart Ways to Cross Drug Development’s “Valley of Death”
Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early testing, smart IP and regulatory planning, and scalable CMC choices can help founders reach first-in-human faster.
April 6, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Sponsored by Altasciences
Common Pitfalls That Delay Regulatory Submissions, and How to Prevent Them
Common early-phase pitfalls, from misaligned nonclinical strategy to gaps in CMC, bioanalysis, and species selection, can delay IND and CTA submissions. By aligning development plans with regulatory expectations from the outset and integrating cross-functional insight, sponsors can reduce rework, strengthen submissions, and maintain momentum toward first-in-human studies.
March 30, 2026
·
7 min read
·
Altasciences
Press Releases
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
October 31, 2025
·
4 min read
Press Releases
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
August 20, 2025
·
3 min read
Press Releases
WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
April 24, 2026
·
4 min read
1 of 10,359
Next